Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain.
Ruiz-Camps I, et al. Among authors: de la torre j, de la camara r.
Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858.
Antivir Ther. 2011.
PMID: 22024510